KV.A: 3.26 +0.08 (2.52%) - K-V Pharmaceutical Company

KV.A: 3.26 +0.08 (2.52%) - K-V Pharmaceutical Company: "Net profit margin 8.42% 14.68%
Operating margin 13.79% 21.66%
EBITD margin - 26.83%
Return on average assets 5.77% 11.21%
Return on average equity 10.86% 21.43%
Employees 1,590"
K-V Pharmaceutical Company (KV) is a fully integrated specialty pharmaceutical company that develops, manufactures, acquires and markets branded and generic/non-branded prescription pharmaceutical products. The Company has a range of dosage form capabilities, including tablets, capsules, creams, liquids and ointments. KV conducts its branded pharmaceutical operations through Ther-Rx Corporation (Ther-Rx) and its generic/non-branded pharmaceutical operations through ETHEX Corporation (ETHEX). Through Particle Dynamics, Inc. (PDI), the Company also develops, manufactures and markets value-added raw material products for the pharmaceutical, nutritional, personal care, food and other markets. The Company has developed a variety of drug delivery and formulation technologies, which are primarily focused in four principal areas: SITE RELEASE; tastemasking; oral controlled release, and oral quick dissolving tablets.

www.stockcaps.blogspot.com